EP2275110
Cladribine regimen for treating Multiple Sclerosis
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2005EP published:
10.7.2013EP application number:
10182632.9
EPO information:
European Patent Register
Max expiry date:
19.12.2025
Title:
Cladribine regimen for treating Multiple Sclerosis
Timeline
Today
20.12.2005EP application
10.7.2013EP Publication
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267, Coinsins, Vaud, CH
Inventor
Name:
De Luca, GiampieroAddress:
Conches, CH
Name:
Ythier, ArnoudAddress:
Collex-Bossy, CH
Name:
Munafo, AlainAddress:
Tartegnin, CH
Name:
Lopez-Bresnahan, MariaAddress:
Lincoln, MA, US
Priority
Number:
638669 PDate:
22.12.2004Country:
US
Number:
04106909Date:
22.12.2004Country:
EP
Classification
Categories:
A61K 31/7076, A61K 38/21, A61P 25/00